Sarepta Therapeutics, Inc. Business Finance Contracts & Agreements

102 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 3 to Sarepta Therapeutics, Inc. Amended and Restated 2013 Employee Stock Purchase Plan
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2025
Amendment No. 4 to Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2025
Credit Agreement among Sarepta Therapeutics, Inc., Lenders, and JPMorgan Chase Bank, N.A. (February 13, 2025)
Credit Agreements
Sarepta Therapeutics, Inc.
Biotechnology
IL
2025
Amendment No. 3 to Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2023
Exchange Agreement between Sarepta Therapeutics, Inc. and Investor for 1.50% Convertible Senior Notes due 2024
Exchange Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2023
Purchase Agreement for 1.25% Convertible Senior Notes between Michael A. Chamber Living Trust and Sarepta Therapeutics, Inc.
Purchase Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2022
Sarepta Therapeutics, Inc. 1.25% Convertible Senior Notes Due 2027 Purchase Agreement with Initial Purchasers
Purchase Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2022
Indenture for 1.250% Convertible Senior Notes due 2027 between Sarepta Therapeutics, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2022
Amendment No. 2 to Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2022
Underwriting Agreement between Sarepta Therapeutics, Inc. and Underwriters for Common Stock Offering
Underwriting Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2021
Amendment No. 1 to Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2020
Description of Sarepta Therapeutics, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2020
Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan – Japan Sub-Plan Schedule
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2019
Amendment to Warrant Agreement Between Sarepta Therapeutics, Inc. and Myonexus Therapeutics, Inc. (February 26, 2019)
Warrant Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2019
Equity Underwriting Agreement between Sarepta Therapeutics, Inc. and Underwriters (Goldman Sachs & Morgan Stanley) dated March 5, 2019
Underwriting Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2019
Equity Underwriting Agreement between Sarepta Therapeutics, Inc. and Underwriters (Goldman Sachs, J.P. Morgan, Credit Suisse)
Underwriting Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2018
Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan Stock Appreciation Right Award Agreement (Stock Settled)
Warrant Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2018
Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2018
Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan Restricted Stock Award Agreement
Stock Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2018
Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan Stock Option Award Agreement
Warrant Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2018
Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2018
Warrant to Purchase Common Stock Agreement between Sarepta Therapeutics, Inc. and Myonexus Therapeutics, Inc. (May 3, 2018)
Warrant Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2018
Indenture for 1.50% Convertible Senior Notes due 2024 between Sarepta Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2017
Sarepta Therapeutics, Inc. 1.500% Convertible Senior Notes due 2024 Purchase Agreement with J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC
Purchase Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2017
Equity Underwriting Agreement between Sarepta Therapeutics, Inc. and Underwriters (Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC) dated July 24, 2017
Underwriting Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2017
Asset Purchase Agreement between Gilead Sciences, Inc. and Sarepta Therapeutics Inc. dated February 20, 2017
Purchase Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2017
Sarepta Therapeutics, Inc. Amended and Restated 2011 Equity Incentive Plan Stock Appreciation Right Award Agreement (Stock Settled)
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2017
Sarepta Therapeutics, Inc. 2011 Equity Incentive Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2017
Sarepta Therapeutics, Inc. Amended and Restated 2011 Equity Incentive Plan Restricted Stock Agreement
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2017
Sarepta Therapeutics, Inc. Amended and Restated 2011 Equity Incentive Plan Stock Option Award Agreement
Equity Distribution Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2017
Supplement to Capped Call Option Transaction Confirmations between Sarepta Therapeutics, Inc. and JPMorgan Chase Bank, N.A.
Modification Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2024
Supplement to Capped Call Option Transaction Confirmations between Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC
Modification Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2024
Amendment to Performance Stock Option, Change in Control, and Employment Agreements between Sarepta Therapeutics, Inc. and Douglas S. Ingram
Modification Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2022
First Amendment to Loan Agreement by Sarepta Therapeutics, Inc. and BioPharma Credit Entities
Loan Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2020
Amendment to Restricted Stock Award Agreement between Sarepta Therapeutics, Inc. and Douglas S. Ingram
Modification Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2019
Amendment to Employment and Change in Control Severance Agreements between Sarepta Therapeutics, Inc. and Douglas S. Ingram
Modification Agreements
Sarepta Therapeutics, Inc.
Biotechnology
MA
2018
First Amendment to Sponsored Research Agreement between AVI BioPharma, Inc. and Charley's Fund, Inc.
Modification Agreements
Sarepta Therapeutics, Inc.
Biotechnology
2018
First Amendment to Credit and Security Agreement by Sarepta Therapeutics, Inc. and MidCap Funding IV Trust
Modification Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2017
First Amendment to Amended and Restated Credit and Security Agreement among Sarepta Therapeutics, Inc., MidCap Financial Trust, and Lenders
Credit Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2017
Amended and Restated Credit and Security Agreement among MidCap Financial Trust, Lenders, and Sarepta Therapeutics, Inc. (July 18, 2017)
Credit Agreements
Sarepta Therapeutics, Inc.
Biotechnology
NY
2017